Xenon Pharmaceuticals (XENE) Selling, General & Administrative (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted Selling, General & Administrative of $23.93 million for Q2 2026, up 24.4% from $19.24 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Xenon Pharmaceuticals was $89.1 million, up 22.1% year-over-year; for FY2025, it was $79.63 million, up 15.6% from FY2024.
- Annual Selling, General & Administrative has increased for nine consecutive years, with a five-year compound annual growth rate of 43.8% (FY2020 to FY2025).
- In prior years, Xenon Pharmaceuticals' Selling, General & Administrative was $68.9 million in FY2024 (+48.0%), $46.54 million in FY2023 (+41.9%), $32.81 million in FY2022 (+49.4%) and $21.97 million in FY2021 (+69.7%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q3 2013.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last four quarters, with growth averaging 23.6% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 115.3%; the weakest was Q2 2025, with a decline of 0.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $23.82 million (Q1 2026), $22.07 million (Q4 2025) and $19.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Xenon Pharmaceuticals | 3.68 Bn | 3.68 Bn | - | 23.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.93 Mn |
| Mar 31, 2026 | 23.82 Mn |
| Dec 31, 2025 | 22.07 Mn |
| Sep 30, 2025 | 19.28 Mn |
| Jun 30, 2025 | 19.24 Mn |
| Mar 31, 2025 | 19.04 Mn |
| Dec 31, 2024 | 18.01 Mn |
| Sep 30, 2024 | 16.71 Mn |
| Jun 30, 2024 | 19.40 Mn |
| Mar 31, 2024 | 14.79 Mn |
| Dec 31, 2023 | 12.62 Mn |
| Sep 30, 2023 | 12.80 Mn |
| Jun 30, 2023 | 11.58 Mn |
| Mar 31, 2023 | 9.54 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 8.83 Mn |
| Jun 30, 2022 | 8.71 Mn |
| Mar 31, 2022 | 6.78 Mn |
| Dec 31, 2021 | 6.69 Mn |
| Sep 30, 2021 | 4.83 Mn |
API Access
Xenon Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();